Gender & AD
Research type
Research Study
Full title
Gender & Alzheimer’s Disease: A mixed-methods retrospective review of data collected in the cognitive clinic.
IRAS ID
259069
Contact name
Natalie Rosewell
Contact email
Sponsor organisation
University of the West of England
Duration of Study in the UK
0 years, 6 months, 20 days
Research summary
This study is looking to explore the effects of gender on the diagnosis of Alzheimer’s disease (AD). AD is the most common form of dementia, it is reported that more women than men are diagnosed with AD but the evidence is conflicting. This is a mixed-methods retrospective study, using retrospective clinical data. The quantitative section of the study will look at diagnosis rates of Alzheimer's Disease in the cognitive clinic to see if there is a significant difference in the number of women versus men diagnosed with Alzheimer’s disease in the cognitive clinic and if there is a significant relationship between gender and; age, years of education and/or past medical history in patients diagnosed with Alzheimer’s disease in the cognitive clinic. The qualitative component will use information collected in clinic referrals, letters, results letters to explore if there are any differences between men and women in the types of problems experienced relating to a diagnosis of AD. The research will be underpinned by a feminist theoretical perspective.
REC name
London - Bromley Research Ethics Committee
REC reference
19/LO/0796
Date of REC Opinion
17 Jun 2019
REC opinion
Further Information Favourable Opinion